CRC for Cell Therapy Manufacturing adds to its expertise with world-renowned RPA / Publication

Royal Prince Alfred Hospital’s Department of Cell And Molecular Therapies, headed by Professor John Rasko AO, joins the CRC for Cell Therapy Manufacturing. This partnership mobilises $1.8 million cash and in-kind investment within the CRC, leveraging over 50 years’ experience in the cell and gene therapy industry at RPA to help realise the CRC’s vision to make cell therapies more affordable and accessible.

Read More